Hogge Gary S. is an officer of Lineage Cell Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Lineage Cell Therapeutics, Inc.
10 Mar 23
4
Lineage Cell Therapeutics, Inc.
14 Feb 23
4
Lineage Cell Therapeutics, Inc.
11 Mar 22
4
Lineage Cell Therapeutics, Inc.
15 Feb 22
4
Lineage Cell Therapeutics, Inc.
30 Dec 21
4
Lineage Cell Therapeutics, Inc.
17 Mar 21
4
Lineage Cell Therapeutics, Inc.
19 Mar 20
3
BIOTIME INC
29 Mar 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Mar 23 | LCTX Lineage Cell Therapeutics | Employee Stock Option Common Shares | Grant | Acquire A | No | No | 1.46 | 400,000 | 584.00 k | 400,000 |
11 Feb 23 | LCTX Lineage Cell Therapeutics | Common Shares, no par value | Payment of exercise | Dispose F | No | No | 1.35 | 5,310 | 7.17 k | 7,710 |
11 Feb 23 | LCTX Lineage Cell Therapeutics | Common Shares, no par value | Option exercise | Acquire M | No | No | 0 | 13,020 | 0.00 | 13,020 |
11 Feb 23 | LCTX Lineage Cell Therapeutics | RSU Common Shares | Option exercise | Dispose M | No | No | 0 | 13,020 | 0.00 | 39,061 |